{"transactions":[{"id":4632417,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO, & CFO"}}],"security":"Common Stock","published_at":"2026-09-30T14:25:37.000Z","date":"2026-09-30","kind":"purchase","planned":false,"acquired":true,"shares":5500,"price":2.84,"value":15620.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-26-045053","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226045053/ownership.xml","form_type":"4"}},{"id":4627302,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-28T12:45:19.000Z","date":"2026-09-24","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":2.78,"value":19460.0,"ownership":{"direct":true},"balance_after":672000,"source":{"system":"sec-edgar","filing":"0001493152-26-044458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191905/000149315226044458/ownership.xml","form_type":"4"}},{"id":4627300,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T12:30:18.000Z","date":"2026-09-24","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.76,"value":13800.0,"ownership":{"direct":true},"balance_after":140572,"source":{"system":"sec-edgar","filing":"0001493152-26-044457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683567/000149315226044457/ownership.xml","form_type":"4"}},{"id":4626672,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-25T12:39:59.000Z","date":"2026-09-23","kind":"purchase","planned":false,"acquired":true,"shares":49036,"price":2.69,"value":131906.84,"ownership":{"direct":true},"balance_after":1046003,"source":{"system":"sec-edgar","filing":"0001493152-26-044250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1499254/000149315226044250/ownership.xml","form_type":"4"}},{"id":4616619,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-14T13:45:02.000Z","date":"2026-09-10","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":2.75,"value":8250.0,"ownership":{"direct":true},"balance_after":665000,"source":{"system":"sec-edgar","filing":"0001493152-26-042512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191905/000149315226042512/ownership.xml","form_type":"4"}},{"id":4616611,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-14T13:15:10.000Z","date":"2026-09-10","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.73,"value":27300.0,"ownership":{"direct":true},"balance_after":996967,"source":{"system":"sec-edgar","filing":"0001493152-26-042502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1499254/000149315226042502/ownership.xml","form_type":"4"}},{"id":4615595,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-11T12:00:26.000Z","date":"2026-09-10","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.76,"value":13800.0,"ownership":{"direct":true},"balance_after":662000,"source":{"system":"sec-edgar","filing":"0001493152-26-042302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191905/000149315226042302/ownership.xml","form_type":"4"}},{"id":699463,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-03T08:45:18.000Z","date":"2026-07-31","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.47,"value":17350.0,"ownership":{"direct":true},"balance_after":657000,"source":{"system":"sec-edgar","filing":"0001493152-26-035751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226035751/ownership.xml","form_type":"4"}},{"id":701862,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-29T09:14:58.000Z","date":"2026-07-27","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated August 23, 2013."}],"balance_after":0,"derivative":{"exercise_price":3.13,"exercise_date":"2016-08-23","expiration_date":"2026-08-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001493152-26-035122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226035122/ownership.xml","form_type":"4"}},{"id":701861,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T09:14:58.000Z","date":"2026-07-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":5428,"price":3.46,"value":18780.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person exercised the stock options at this time due to their expiration on August 23, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to cover the exercise price of the stock options."}],"balance_after":135572,"source":{"system":"sec-edgar","filing":"0001493152-26-035122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226035122/ownership.xml","form_type":"4"}},{"id":701860,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T09:14:58.000Z","date":"2026-07-27","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":3.13,"value":18780.0,"ownership":{"direct":true},"balance_after":141000,"source":{"system":"sec-edgar","filing":"0001493152-26-035122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226035122/ownership.xml","form_type":"4"}},{"id":702601,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-28T10:20:30.000Z","date":"2026-07-27","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.44,"value":17200.0,"ownership":{"direct":true},"balance_after":652000,"source":{"system":"sec-edgar","filing":"0001493152-26-034952","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226034952/ownership.xml","form_type":"4"}},{"id":703245,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-27T15:25:14.000Z","date":"2026-07-27","kind":"purchase","planned":false,"acquired":true,"shares":3188,"price":3.37,"value":10743.56,"ownership":{"direct":true},"balance_after":647000,"source":{"system":"sec-edgar","filing":"0001493152-26-034772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226034772/ownership.xml","form_type":"4"}},{"id":703246,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-27T09:00:29.000Z","date":"2026-07-24","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":3.73,"value":11190.0,"ownership":{"direct":true},"balance_after":643812,"source":{"system":"sec-edgar","filing":"0001493152-26-034723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226034723/ownership.xml","form_type":"4"}},{"id":705400,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-21T10:23:18.000Z","date":"2026-07-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.46,"value":17300.0,"ownership":{"direct":true},"balance_after":640812,"source":{"system":"sec-edgar","filing":"0001493152-26-034027","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226034027/ownership.xml","form_type":"4"}},{"id":706101,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-20T18:19:30.000Z","date":"2026-07-20","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":3.47,"value":41640.0,"ownership":{"direct":true},"balance_after":986967,"source":{"system":"sec-edgar","filing":"0001493152-26-033949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226033949/ownership.xml","form_type":"4"}},{"id":708553,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-16T09:00:10.000Z","date":"2026-07-15","kind":"purchase","planned":false,"acquired":true,"shares":2797,"price":3.28,"value":9174.16,"ownership":{"direct":true},"balance_after":974967,"source":{"system":"sec-edgar","filing":"0001493152-26-033461","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226033461/ownership.xml","form_type":"4"}},{"id":710907,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-13T08:59:58.000Z","date":"2026-07-10","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.04,"value":15200.0,"ownership":{"direct":true},"balance_after":635812,"source":{"system":"sec-edgar","filing":"0001493152-26-032961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226032961/ownership.xml","form_type":"4"}},{"id":735274,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T11:21:16.000Z","date":"2026-06-16","kind":"purchase","planned":false,"acquired":true,"shares":2836,"price":2.64,"value":7487.04,"ownership":{"direct":true},"balance_after":972170,"source":{"system":"sec-edgar","filing":"0001493152-26-029030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226029030/ownership.xml","form_type":"4"}},{"id":737109,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-16T09:00:11.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":21000,"price":2.5,"value":52500.0,"ownership":{"direct":true},"balance_after":630812,"source":{"system":"sec-edgar","filing":"0001493152-26-028827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226028827/ownership.xml","form_type":"4"}},{"id":928362,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-29T08:58:38.000Z","date":"2026-01-28","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.04,"value":30400.0,"ownership":{"direct":true},"balance_after":135000,"source":{"system":"sec-edgar","filing":"0001493152-26-004148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226004148/ownership.xml","form_type":"4"}},{"id":949151,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2026-01-06T19:44:03.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026."}],"balance_after":25000,"derivative":{"exercise_price":3.18,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-000689","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226000689/ownership.xml","form_type":"4"}},{"id":949150,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2026-01-06T19:42:43.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026."}],"balance_after":350000,"derivative":{"exercise_price":3.18,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-26-000688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226000688/ownership.xml","form_type":"4"}},{"id":949149,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70193,"kind":"person","name":"Gottschalk Emily","position":1,"cik":"0001791108","reported_name":"Gottschalk Emily","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2026-01-06T19:41:53.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026."}],"balance_after":25000,"derivative":{"exercise_price":3.18,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-000687","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226000687/ownership.xml","form_type":"4"}},{"id":949148,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & CFO"}}],"security":"Employee Stock Option","published_at":"2026-01-06T19:41:04.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026."}],"balance_after":175000,"derivative":{"exercise_price":3.18,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001493152-26-000686","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226000686/ownership.xml","form_type":"4"}},{"id":949147,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2026-01-06T19:40:10.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026."}],"balance_after":25000,"derivative":{"exercise_price":3.18,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-000685","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226000685/ownership.xml","form_type":"4"}},{"id":968464,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2025-12-16T08:56:24.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated February 18, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.92,"exercise_date":"2016-02-18","expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-25-027904","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225027904/ownership.xml","form_type":"4"}},{"id":968463,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T08:56:24.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":2.92,"value":46720.0,"ownership":{"direct":true},"balance_after":969334,"source":{"system":"sec-edgar","filing":"0001493152-25-027904","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225027904/ownership.xml","form_type":"4"}},{"id":1011080,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-31T09:13:33.000Z","date":"2025-10-30","kind":"exercise","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated February 18, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in 36 consecutive monthly installments beginning on March 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.92,"expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-25-020322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225020322/ownership.xml","form_type":"4"}},{"id":1011079,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-31T09:13:33.000Z","date":"2025-10-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":169439,"price":4.06,"value":687922.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person exercised the stock options at this time due to their upcoming expiration on February 18, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options."}],"balance_after":610486,"source":{"system":"sec-edgar","filing":"0001493152-25-020322","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225020322/ownership.xml","form_type":"4"}},{"id":1011078,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-31T09:13:33.000Z","date":"2025-10-30","kind":"exercise","planned":false,"acquired":true,"shares":200000,"price":2.92,"value":584000.0,"ownership":{"direct":true},"balance_after":779925,"source":{"system":"sec-edgar","filing":"0001493152-25-020322","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225020322/ownership.xml","form_type":"4"}},{"id":1077127,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-04T09:00:05.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.08,"value":30800.0,"ownership":{"direct":true},"balance_after":953334,"source":{"system":"sec-edgar","filing":"0001641172-25-022000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225022000/ownership.xml","form_type":"4"}},{"id":1078741,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-31T09:00:04.000Z","date":"2025-07-30","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.16,"value":15800.0,"ownership":{"direct":true},"balance_after":579925,"source":{"system":"sec-edgar","filing":"0001641172-25-021679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225021679/ownership.xml","form_type":"4"}},{"id":1084406,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T08:30:06.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.39,"value":16950.0,"ownership":{"direct":true},"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001641172-25-020362","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225020362/ownership.xml","form_type":"4"}},{"id":1087785,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-15T06:03:41.000Z","date":"2025-07-11","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.14,"value":31400.0,"ownership":{"direct":true},"balance_after":943334,"source":{"system":"sec-edgar","filing":"0001641172-25-019587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225019587/ownership.xml","form_type":"4"}},{"id":1088310,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-14T08:40:10.000Z","date":"2025-07-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.15,"value":15750.0,"ownership":{"direct":true},"balance_after":574925,"source":{"system":"sec-edgar","filing":"0001641172-25-018898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225018898/ownership.xml","form_type":"4"}},{"id":1122135,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T09:11:56.000Z","date":"2025-06-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.85,"value":28500.0,"ownership":{"direct":true},"balance_after":569925,"source":{"system":"sec-edgar","filing":"0001641172-25-013724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225013724/ownership.xml","form_type":"4"}},{"id":1292387,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-29T10:06:40.000Z","date":"2025-01-28","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.82,"value":14100.0,"ownership":{"direct":true},"balance_after":120000,"source":{"system":"sec-edgar","filing":"0001493152-25-004108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225004108/ownership.xml","form_type":"4"}},{"id":1294967,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-27T09:14:35.000Z","date":"2025-01-24","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3,"value":3000.0,"ownership":{"direct":true},"balance_after":933334,"source":{"system":"sec-edgar","filing":"0001493152-25-003733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225003733/ownership.xml","form_type":"4"}},{"id":1294966,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-27T09:14:35.000Z","date":"2025-01-23","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.91,"value":5820.0,"ownership":{"direct":true},"balance_after":932334,"source":{"system":"sec-edgar","filing":"0001493152-25-003733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225003733/ownership.xml","form_type":"4"}},{"id":1297046,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-23T09:11:08.000Z","date":"2025-01-22","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.01,"value":6020.0,"ownership":{"direct":true},"balance_after":930334,"source":{"system":"sec-edgar","filing":"0001493152-25-003330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225003330/ownership.xml","form_type":"4"}},{"id":1298352,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-22T09:13:23.000Z","date":"2025-01-21","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":2.59,"value":15540.0,"ownership":{"direct":true},"balance_after":928334,"source":{"system":"sec-edgar","filing":"0001493152-25-003157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225003157/ownership.xml","form_type":"4"}},{"id":1301115,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T14:05:27.000Z","date":"2025-01-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.57,"value":25700.0,"ownership":{"direct":true},"balance_after":922334,"source":{"system":"sec-edgar","filing":"0001493152-25-002717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225002717/ownership.xml","form_type":"4"}},{"id":1302952,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-15T13:15:32.000Z","date":"2025-01-15","kind":"purchase","planned":false,"acquired":true,"shares":43000,"price":2.23,"value":95890.0,"ownership":{"direct":true},"balance_after":559925,"source":{"system":"sec-edgar","filing":"0001493152-25-002321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225002321/ownership.xml","form_type":"4"}},{"id":1302951,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO, & CFO"}}],"security":"Common Stock","published_at":"2025-01-15T12:48:10.000Z","date":"2025-01-15","kind":"purchase","planned":false,"acquired":true,"shares":9289,"price":2.15,"value":19971.35,"ownership":{"direct":true},"balance_after":44500,"source":{"system":"sec-edgar","filing":"0001493152-25-002314","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225002314/ownership.xml","form_type":"4"}},{"id":1317637,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2025-01-03T17:40:36.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025."}],"balance_after":25000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-25-000317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225000317/ownership.xml","form_type":"4"}},{"id":1317635,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70193,"kind":"person","name":"Gottschalk Emily","position":1,"cik":"0001791108","reported_name":"Gottschalk Emily","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2025-01-03T17:40:35.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025."}],"balance_after":25000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-25-000315","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225000315/ownership.xml","form_type":"4"}},{"id":1317636,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2025-01-03T17:40:34.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2025."}],"balance_after":700000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001493152-25-000316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225000316/ownership.xml","form_type":"4"}},{"id":1317634,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2025-01-03T17:40:32.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025."}],"balance_after":25000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-25-000313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225000313/ownership.xml","form_type":"4"}},{"id":1317633,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & CFO"}}],"security":"Employee Stock Option","published_at":"2025-01-03T17:40:31.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2025."}],"balance_after":350000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-25-000314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225000314/ownership.xml","form_type":"4"}},{"id":1382667,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2024-10-23T11:27:57.000Z","date":"2024-10-22","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated January 2, 2015."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2015-01-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-24-042183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224042183/ownership.xml","form_type":"4"}},{"id":1382666,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-23T11:27:57.000Z","date":"2024-10-22","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":2.575,"value":41200.0,"ownership":{"direct":true},"balance_after":912334,"source":{"system":"sec-edgar","filing":"0001493152-24-042183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224042183/ownership.xml","form_type":"4"}},{"id":1444879,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T12:42:57.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":5580,"price":3.23,"value":18023.4,"ownership":{"direct":true},"balance_after":896334,"source":{"system":"sec-edgar","filing":"0001493152-24-029884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029884/ownership.xml","form_type":"4"}},{"id":1444878,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T12:42:57.000Z","date":"2024-07-30","kind":"purchase","planned":false,"acquired":true,"shares":21646,"price":3.06,"value":66236.76,"ownership":{"direct":true},"balance_after":890754,"source":{"system":"sec-edgar","filing":"0001493152-24-029884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029884/ownership.xml","form_type":"4"}},{"id":1447731,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-29T06:05:44.000Z","date":"2024-07-26","kind":"purchase","planned":false,"acquired":true,"shares":7700,"price":3.03,"value":23331.0,"ownership":{"direct":true},"balance_after":869108,"source":{"system":"sec-edgar","filing":"0001493152-24-029354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029354/ownership.xml","form_type":"4"}},{"id":1447730,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-29T06:05:44.000Z","date":"2024-07-25","kind":"purchase","planned":false,"acquired":true,"shares":796,"price":2.81,"value":2236.76,"ownership":{"direct":true},"balance_after":861408,"source":{"system":"sec-edgar","filing":"0001493152-24-029354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029354/ownership.xml","form_type":"4"}},{"id":1448436,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T13:26:12.000Z","date":"2024-07-26","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.09,"value":15450.0,"ownership":{"direct":true},"balance_after":115000,"source":{"system":"sec-edgar","filing":"0001493152-24-029191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029191/ownership.xml","form_type":"4"}},{"id":1476559,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T09:22:37.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":2.68,"value":10720.0,"ownership":{"direct":true},"balance_after":860612,"source":{"system":"sec-edgar","filing":"0001493152-24-024226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224024226/ownership.xml","form_type":"4"}},{"id":1479983,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T09:56:44.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":405,"price":2.7,"value":1093.5,"ownership":{"direct":true},"balance_after":856612,"source":{"system":"sec-edgar","filing":"0001493152-24-023802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023802/ownership.xml","form_type":"4"}},{"id":1482686,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T11:18:04.000Z","date":"2024-06-11","kind":"purchase","planned":false,"acquired":true,"shares":7102,"price":2.66,"value":18891.32,"ownership":{"direct":true},"balance_after":856207,"source":{"system":"sec-edgar","filing":"0001493152-24-023560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023560/ownership.xml","form_type":"4"}},{"id":1482685,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T11:18:04.000Z","date":"2024-06-10","kind":"purchase","planned":false,"acquired":true,"shares":330,"price":2.6,"value":858.0,"ownership":{"direct":true},"balance_after":849105,"source":{"system":"sec-edgar","filing":"0001493152-24-023560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023560/ownership.xml","form_type":"4"}},{"id":1485802,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T10:03:11.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":10738,"price":2.52,"value":27059.76,"ownership":{"direct":true},"balance_after":848775,"source":{"system":"sec-edgar","filing":"0001493152-24-023295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023295/ownership.xml","form_type":"4"}},{"id":1487747,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO, & CFO"}}],"security":"Common Stock","published_at":"2024-06-07T12:24:19.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":6250,"price":2.4,"value":15000.0,"ownership":{"direct":true},"balance_after":35211,"source":{"system":"sec-edgar","filing":"0001493152-24-023037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023037/ownership.xml","form_type":"4"}},{"id":1487746,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-07T10:57:50.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.41,"value":60250.0,"ownership":{"direct":true},"balance_after":516925,"source":{"system":"sec-edgar","filing":"0001493152-24-023023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023023/ownership.xml","form_type":"4"}},{"id":1531205,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO, & CFO"}}],"security":"Common Stock","published_at":"2024-05-02T09:19:52.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":1189,"price":2.52,"value":2996.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the \"Plan\") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on April 30, 2024."}],"balance_after":28961,"source":{"system":"sec-edgar","filing":"0001493152-24-017496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224017496/ownership.xml","form_type":"4"}},{"id":1544120,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-10T09:44:51.000Z","date":"2024-04-09","kind":"purchase","planned":false,"acquired":true,"shares":15009,"price":3.28,"value":49229.52,"ownership":{"direct":true},"balance_after":838037,"source":{"system":"sec-edgar","filing":"0001493152-24-014154","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224014154/ownership.xml","form_type":"4"}},{"id":1575813,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-15T14:15:37.000Z","date":"2024-03-15","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.63,"value":36300.0,"ownership":{"direct":true},"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001493152-24-010060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010060/ownership.xml","form_type":"4"}},{"id":1575812,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-15T10:49:36.000Z","date":"2024-03-15","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":3.22,"value":96600.0,"ownership":{"direct":true},"balance_after":491925,"source":{"system":"sec-edgar","filing":"0001493152-24-010028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010028/ownership.xml","form_type":"4"}},{"id":1679560,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-16T19:08:30.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2024."}],"balance_after":25000,"derivative":{"exercise_price":4.39,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-002531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224002531/ownership.xml","form_type":"4"}},{"id":1679559,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70193,"kind":"person","name":"Gottschalk Emily","position":1,"cik":"0001791108","reported_name":"Gottschalk Emily","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-16T19:07:48.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2024."}],"balance_after":25000,"derivative":{"exercise_price":4.39,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-002530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224002530/ownership.xml","form_type":"4"}},{"id":1679558,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-16T19:07:08.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2024."}],"balance_after":350000,"derivative":{"exercise_price":4.39,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-24-002529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224002529/ownership.xml","form_type":"4"}},{"id":1679557,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-16T19:05:55.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2024."}],"balance_after":700000,"derivative":{"exercise_price":4.39,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001493152-24-002527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224002527/ownership.xml","form_type":"4"}},{"id":1679556,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-16T19:05:16.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2024."}],"balance_after":25000,"derivative":{"exercise_price":4.39,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-002526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224002526/ownership.xml","form_type":"4"}},{"id":1751990,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & CFO"}}],"security":"Common Stock","published_at":"2023-11-02T10:58:20.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":1117,"price":2.69,"value":3004.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the \"Plan\") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on October 31, 2023."}],"balance_after":27772,"source":{"system":"sec-edgar","filing":"0001493152-23-039093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223039093/ownership.xml","form_type":"4"}},{"id":1762250,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2023-10-11T10:35:57.000Z","date":"2023-10-10","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated January 2, 2014."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2014-01-02","expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-23-036871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223036871/ownership.xml","form_type":"4"}},{"id":1762249,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-11T10:35:57.000Z","date":"2023-10-10","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":2.575,"value":41200.0,"ownership":{"direct":true},"balance_after":823028,"source":{"system":"sec-edgar","filing":"0001493152-23-036871","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223036871/ownership.xml","form_type":"4"}},{"id":1821076,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-31T18:36:13.000Z","date":"2023-07-27","kind":"exercise","planned":false,"acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated November 8, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2013-11-08","expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-23-026127","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026127/ownership.xml","form_type":"4"}},{"id":1821075,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-31T18:36:13.000Z","date":"2023-07-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":87042,"price":3.55,"value":308999.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to cover the exercise price of the stock options."}],"balance_after":807028,"source":{"system":"sec-edgar","filing":"0001493152-23-026127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026127/ownership.xml","form_type":"4"}},{"id":1821074,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-31T18:36:13.000Z","date":"2023-07-27","kind":"exercise","planned":false,"acquired":true,"shares":120000,"price":2.575,"value":309000.0,"ownership":{"direct":true},"balance_after":894070,"source":{"system":"sec-edgar","filing":"0001493152-23-026127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026127/ownership.xml","form_type":"4"}},{"id":1821073,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-31T18:34:37.000Z","date":"2023-07-28","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated November 8, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2013-11-08","expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-026125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026125/ownership.xml","form_type":"4"}},{"id":1821072,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-31T18:34:37.000Z","date":"2023-07-31","kind":"sale","planned":false,"acquired":false,"shares":11800,"price":3.57,"value":42126.0,"ownership":{"direct":true},"balance_after":461925,"source":{"system":"sec-edgar","filing":"0001493152-23-026125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026125/ownership.xml","form_type":"4"}},{"id":1821071,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-31T18:34:37.000Z","date":"2023-07-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":28375,"price":3.63,"value":103001.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to cover the exercise price of the stock options."}],"balance_after":473725,"source":{"system":"sec-edgar","filing":"0001493152-23-026125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026125/ownership.xml","form_type":"4"}},{"id":1821070,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-31T18:34:37.000Z","date":"2023-07-28","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":2.575,"value":103000.0,"ownership":{"direct":true},"balance_after":502100,"source":{"system":"sec-edgar","filing":"0001493152-23-026125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026125/ownership.xml","form_type":"4"}},{"id":1825309,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & CFO"}}],"security":"Common Stock","published_at":"2023-07-21T10:06:58.000Z","date":"2023-07-20","kind":"purchase","planned":false,"acquired":true,"shares":5500,"price":3.64,"value":20020.0,"ownership":{"direct":true},"balance_after":26655,"source":{"system":"sec-edgar","filing":"0001493152-23-025185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223025185/ownership.xml","form_type":"4"}},{"id":1910864,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & CFO"}}],"security":"Common Stock","published_at":"2023-05-01T10:45:54.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":865,"price":3.47,"value":3001.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the \"Plan\") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on April 28, 2023."}],"balance_after":21155,"source":{"system":"sec-edgar","filing":"0001493152-23-014890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223014890/ownership.xml","form_type":"4"}},{"id":2071077,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70193,"kind":"person","name":"Gottschalk Emily","position":1,"cik":"0001791108","reported_name":"Gottschalk Emily","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-04T20:58:10.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2023."}],"balance_after":25000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-000424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223000424/ownership.xml","form_type":"4"}},{"id":2071076,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-04T20:53:19.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2023."}],"balance_after":350000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-23-000422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223000422/ownership.xml","form_type":"4"}},{"id":2071075,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-04T20:52:33.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2023."}],"balance_after":25000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-000421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223000421/ownership.xml","form_type":"4"}},{"id":2071074,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-04T20:50:37.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2023."}],"balance_after":25000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-000418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223000418/ownership.xml","form_type":"4"}},{"id":2071073,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-04T20:49:49.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2023."}],"balance_after":700000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001493152-23-000417","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223000417/ownership.xml","form_type":"4"}},{"id":2129066,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":70192,"kind":"person","name":"Catelani Michael","position":1,"cik":"0001689394","reported_name":"Catelani Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & CFO"}}],"security":"Common Stock","published_at":"2022-11-01T10:20:51.000Z","date":"2022-10-31","kind":"other","acquired":true,"shares":1069,"price":2.81,"value":3003.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the \"Plan\") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on May 2, 2022."}],"balance_after":20290,"source":{"system":"sec-edgar","filing":"0001493152-22-030070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222030070/ownership.xml","form_type":"4"}},{"id":2149090,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2022-09-30T10:34:25.000Z","date":"2022-09-29","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated February 15, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2013-02-15","expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-027222","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222027222/ownership.xml","form_type":"4"}},{"id":2149089,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-30T10:34:25.000Z","date":"2022-09-29","kind":"exercise","acquired":true,"shares":40000,"price":2.575,"value":103000.0,"ownership":{"direct":true},"balance_after":774070,"source":{"system":"sec-edgar","filing":"0001493152-22-027222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222027222/ownership.xml","form_type":"4"}},{"id":2157995,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-09-16T17:20:18.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":640000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated September 19, 2012."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2012-09-19","expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":640000},"source":{"system":"sec-edgar","filing":"0001493152-22-026121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222026121/ownership.xml","form_type":"4"}},{"id":2157994,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-16T17:20:18.000Z","date":"2022-09-15","kind":"tax_withholding","acquired":false,"shares":491900,"price":4.48,"value":2203712.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting persons exercised the stock options at this time due to their expiration on September 19, 2022. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options."}],"balance_after":462100,"source":{"system":"sec-edgar","filing":"0001493152-22-026121","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222026121/ownership.xml","form_type":"4"}},{"id":2157993,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-16T17:20:18.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":640000,"price":2.575,"value":1648000.0,"ownership":{"direct":true},"balance_after":954000,"source":{"system":"sec-edgar","filing":"0001493152-22-026121","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222026121/ownership.xml","form_type":"4"}},{"id":2157992,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T17:08:23.000Z","date":"2022-09-14","kind":"gift","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of two separate bona fide gift transactions exempt under Rule 16b-5. No shares were sold in this transaction. Mr. Titterton transferred the shares to his children for estate planning purposes."}],"balance_after":734070,"source":{"system":"sec-edgar","filing":"0001493152-22-026101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222026101/ownership.xml","form_type":"4"}},{"id":2220643,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2022-06-28T10:21:32.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated March 28, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2013-03-28","expiration_date":"2022-12-31","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-22-017926","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222017926/ownership.xml","form_type":"4"}},{"id":2220642,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2022-06-28T10:21:32.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated September 19, 2012."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2012-09-19","expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-22-017926","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222017926/ownership.xml","form_type":"4"}},{"id":2220641,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T10:21:32.000Z","date":"2022-06-24","kind":"exercise","acquired":true,"shares":16000,"price":2.575,"value":41200.0,"ownership":{"direct":true},"balance_after":1034070,"source":{"system":"sec-edgar","filing":"0001493152-22-017926","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222017926/ownership.xml","form_type":"4"}}],"next_cursor":"2022-06-28T10:21:32.000000Z,2220641"}